Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.54% |
| 2 | Technology | 3.36% |
| 3 | Financials | 2.95% |
| 4 | Consumer Discretionary | 2.92% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Vir Biotechnology
VIR
$1.56B
| $6.74M | ﹤0.01% |
+164,529
| New | +$5.52M |
|
|
BLUE
2527
DELISTED
bluebird bio
BLUE
| $6.73M | ﹤0.01% |
8,513
-73,794
| -90% | -$55.6M |
|
2528
Equinor
EQNR
$96.8B
| $6.73M | ﹤0.01% |
464,831
-284,941
| -38% | -$4M |
|
2529
PUT
Canadian Natural Resources
CNQ
$98.9B
| $6.73M | ﹤0.01% |
788,008
+294,865
| +60% | +$2.38M |
|
2530
PUT
ProShares Ultra QQQ
QLD
$14.4B
| $6.72M | ﹤0.01% |
364,000
-56,000
| -13% | -$859K |
|
|
DNKN
2531
PUT
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $6.72M | ﹤0.01% |
103,000
+19,200
| +23% | +$1.19M |
|
2532
PUT
Old Dominion Freight Line
ODFL
$43.7B
| $6.72M | ﹤0.01% |
79,200
+8,600
| +12% | +$653K |
|
2533
CALL
ProShares UltraPro Short S&P 500
SPXU
$380M
| $6.71M | ﹤0.01% |
5,688
+1,296
| +30% | +$1.97M |
|
2534
SelectQuote
SLQT
$129M
| $6.71M | ﹤0.01% |
+264,934
| New | +$7.11M |
|
|
GES
2535
PUT
DELISTED
Guess Inc
GES
| $6.71M | ﹤0.01% |
693,800
+590,600
| +572% | +$5.2M |
|
2536
CALL
Qualys
QLYS
$6.44B
| $6.71M | ﹤0.01% |
64,500
+32,500
| +102% | +$3.4M |
|
2537
PUT
Pultegroup
PHM
$24.8B
| $6.7M | ﹤0.01% |
196,900
+2,200
| +1% | +$66.1K |
|
2538
PUT
Copart
CPRT
$29.3B
| $6.7M | ﹤0.01% |
321,600
-6,400
| -2% | -$128K |
|
2539
PUT
Ameriprise Financial
AMP
$50.3B
| $6.69M | ﹤0.01% |
44,600
-4,400
| -9% | -$564K |
|
2540
PUT
iShares MSCI Hong Kong ETF
EWH
$1.21B
| $6.69M | ﹤0.01% |
313,100
-120,200
| -28% | -$2.54M |
|
2541
Cue Biopharma
CUE
$233M
| $6.69M | ﹤0.01% |
9,096
+8,462
| +1,335% | +$6.13M |
|
2542
CALL
WEX
WEX
$6.54B
| $6.68M | ﹤0.01% |
40,500
+31,400
| +345% | +$4.31M |
|
2543
CALL
Invesco Senior Loan ETF
BKLN
$6.76B
| $6.68M | ﹤0.01% |
312,900
-245,600
| -44% | -$5.19M |
|
2544
WisdomTree International SmallCap Dividend Fund
DLS
$1.09B
| $6.67M | ﹤0.01% |
119,904
+61,588
| +106% | +$3.26M |
|
2545
Tower Semiconductor
TSEM
$30B
| $6.67M | ﹤0.01% |
349,301
-37,685
| -10% | -$721K |
|
2546
American Water Works
AWK
$27.1B
| $6.66M | ﹤0.01% |
51,792
+3,642
| +8% | +$454K |
|
2547
iShares Expanded Tech Sector ETF
IGM
$10.9B
| $6.66M | ﹤0.01% |
143,208
+40,212
| +39% | +$1.69M |
|
2548
PUT
Chemours
CC
$2.39B
| $6.63M | ﹤0.01% |
432,200
+221,300
| +105% | +$2.8M |
|
2549
Four Corners Property Trust
FCPT
$2.77B
| $6.63M | ﹤0.01% |
271,658
+118,157
| +77% | +$2.53M |
|
2550
ePlus
PLUS
$2.31B
| $6.62M | ﹤0.01% |
187,390
-38,158
| -17% | -$1.3M |
|
Similar funds
Ken Griffin's Q2 2020 Portfolio in Review
As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.1% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.
- Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
- Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.